CELLPOINT vs GRAVISSHO: Stock Comparison
GRAVISSHO is the larger company by market capitalisation. CELLPOINT shows a higher net margin, while GRAVISSHO shows a higher ROE, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
CELLPOINT leads 3; GRAVISSHO leads 5 of 11
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Price
| Metric | CELLPOINT | GRAVISSHO |
|---|---|---|
| Live Price | — | ₹42.37 |
| Day Change | — | -9.79% |
| Volume | — | 94,415 |
| 52-Week High | — | ₹49.9 |
| 52-Week Low | — | ₹25.2 |
| Distance from 52W High | — | -15.09% |
Valuation
| Metric | CELLPOINT | GRAVISSHO |
|---|---|---|
| Market Cap | ₹27 Cr | ₹270 Cr |
| P/E Ratio | — | 0x |
| P/B Ratio | — | 1.1x |
| EPS | ₹0.03 | ₹-0.22 |
| Book Value | ₹39.77 | ₹27.21 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | CELLPOINT | GRAVISSHO |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 0% |
| EPS Growth (TTM YoY) | 0% | 0% |
| Qtr Sales Growth | 107.94% | 2.83% |
| Qtr Profit Growth | -66.67% | -52% |
Profitability & Leverage
| Metric | CELLPOINT | GRAVISSHO |
|---|---|---|
| ROE | 0.09% | 1.5% |
| ROCE | 0.34% | 1.64% |
| Net Margin | 0% | -1.03% |
| Operating Margin | 2.01% | 8.78% |
| Debt to Equity | 1.04x | 0.01x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | CELLPOINT | GRAVISSHO |
|---|---|---|
| Promoter Holding | 73.06% | 71.5% |
| FII Holding | 0% | — |
| DII Holding | 0% | 0% |
| Public Holding | 26.94% | 25.08% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: CELLPOINT and GRAVISSHO.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.